Report 2017

Balance sheet and financial position

Total assets

Total assets decreased from DKK 18,659 million at December 31, 2016, to DKK 18,373 million at December 31, 2017. The decrease was mainly caused by changes in currency, the divestment of Albumedix and the write-down of DKK 120 million on a financial asset related to a guarantee from M&G, partly offset by higher net investments.


ROIC 

Return on invested capital (ROIC) Adjusted operating profit (NOPAT) after tax as a percentage of average invested capital. EBIT is adjusted for net foreign exchange gains/ losses and share of result in associates., including goodwill, was 25.6%, up 0.5 percentage points from 25.1% in 2016. The increase was mainly a result of a higher EBIT Earnings before interest and tax. See operating profit. and a lower tax rate, partly offset by higher net investments. 

Invested capital

Invested capital increased from DKK 12,584 million in 2016 to DKK 12,880 million in 2017. This was mainly a result of high net investments, partly offset by the impact of changes in currency. 


Net working capital 

Novozymes’ net working capitalAll current assets less current liabilities used in, or necessary for, the company’s operations. The main components are inventories, trade receivables and trade payables. decreased to DKK 2,023 million, down from DKK 2,088 million in 2016, mainly due to an increase in trade payables and a decrease in trade receivables, which has been partly offset by release of deferred income.

 

Net interest-bearing debt

Novozymes had net interest-bearing debtThe market value of interest-bearing liabilities (financial liabilities) less the market value of cash at bank and in hand and other easily convertible interest-bearing current assets. of DKK 1,642 million at December 31, 2017, compared with DKK 990 million at December 31, 2016. Net interest-bearing debt was impacted by cash outflows from dividend payments of DKK 1,192 million, stock buybacks of DKK 2,000 million and net investments of DKK 1,668 million, which exceeded cash inflows from operating activities of DKK 4,063 million.


Net interest-bearing debt-to-EBITDA

Net interest-bearing debt-to-EBITDA Net interest-bearing debt divided by EBITDA was 0.3 at December 31, 2017, compared with 0.2 at December 31, 2016. 

 

Assets
DKK million Note Dec. 31, 2017 Dec. 31, 2016
Intangible assets 2.13.1 2,432 2,737
Land and buildings 2.13.2 2,697 2,931
Plant and machinery 2.1, 3.2 4,019 4,239
Other equipment 2.1, 3.2 562 615
Assets under construction and prepayments 2.1, 3.2 1,648 856
Deferred tax assets 2.6 755 607
Other financial assets 29 151
Investments in associates 3.4 59 73
Other receivables 4.3 35 57
Non-current assets 12,236 12,266
Inventories 4.1 2,586 2,488
Trade receivables 4.2 2,554 2,680
Tax receivables 2.6 135 142
Other receivables 4.3 214 267
Other financial assets 16 4
Cash and cash equivalents 6.6 632 812
Current assets 6,137 6,393
Assets 18,373 18,659
Liabilities and shareholders' equity
DKK million Note Dec. 31, 2017 Dec. 31, 2016
Common stock 5.5 610 620
Currency translation adjustments (262) 670
Cash flow hedges 45 (41)
Retained earnings 10,861 10,483
Equity attributable to shareholders in Novozymes A/S 11,254 11,732
Non-controlling interests 13 13
Shareholders' equity 11,267 11,745
Deferred tax liabilities 2.6 721 854
Provisions 3.3 159 231
Deferred income 4.4 337 540
Other financial liabilities 5.3 1,312 1,727
Non-current liabilities 2,529 3,352
Provisions 3.3 86 61
Other financial liabilities 5.3 979 200
Trade payables 1,341 1,194
Deferred income 4.4 205 248
Tax payables 2.6 483 437
Other liabilities 4.5 1,483 1,422
Current liabilities 4,577 3,562
Liabilities 7,106 6,914
Liabilities and shareholders' equity 18,373 18,659
ROIC and invested capital
DKK million %
Created with Highcharts 5.0.0 2013 2014 2015 2016 2017 0 20 40 60 0 5,000 10,000 15,000
  • Average invested capital
  • ROIC
Net working capital
% of sales
Created with Highcharts 5.0.0 2013 2014 2015 2016 2017 (40) (20) 0 20 40
  • Inventories
  • Receivables
  • Payables and deferred income
  • Net working capital
Net interest-bearing debt (NIBD)  and net interest­bearing debt-­to-­EBITDA
DKK million NIBD/EBITDA
Created with Highcharts 5.0.0 2013 2014 2015 2016 2017 (0.5) 0.0 0.5 1.0 (1,000) 0 1,000 2,000
  • NIBD
  • NIBD/EBITDA